1887
  1. Home
  2. Eurosurveillance
  3. Volume 23, Issue 25, 21/Jun/2018
  4. Article
Research article Open Access
Like 0
Download

Abstract

Background

Large measles and mumps outbreaks recently occurred throughout Europe and the United States. : Our aim was to estimate and map the risk of resurgence for measles, mumps and rubella in France. : We used a multi-cohort model combining seroprevalence information, vaccine coverage and social contact data. : The overall outbreak risk for France in 2018 was highest for mumps, remained significant for measles despite a recent measles outbreak and was low for rubella. Outbreak risks were heterogeneous between departments, as the effective reproduction numbers for 2018 ranged from 1.08 to 3.66. The seroprevalence, and therefore the risk of measles and rubella infection, differed significantly between males and females. There was a lower seroprevalence, and therefore a higher risk, for males. Infants of less than 1 year would be seriously affected in a future outbreak of measles, mumps or rubella, but the highest overall caseload contribution would come from teenagers and young adults (10–25 years old). : The high risk for teenagers and young adults is of concern in view of their vulnerability to more severe measles, mumps and rubella disease and complications.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2018.23.25.1700796
2018-06-21
2024-11-20
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2018.23.25.1700796
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/23/25/eurosurv-23-25-1.html?itemId=/content/10.2807/1560-7917.ES.2018.23.25.1700796&mimeType=html&fmt=ahah

References

  1. World Health Organization Regional Office for Europe (WHO/Europe). Package for accelerated action 2013-2015. Copenhagen: WHO/Europe; 2013. Available from: http://www.euro.who.int/__data/assets/pdf_file/0020/215480/PACKAGE-FOR-ACCELERATED-ACTION-20132015.pdf?ua=1
  2. Antona D, Lévy-Bruhl D, Baudon C, Freymuth F, Lamy M, Maine C, et al. Measles elimination efforts and 2008-2011 outbreak, France. Emerg Infect Dis. 2013;19(3):357-64.  https://doi.org/10.3201/eid1903.121360  PMID: 23618523 
  3. Institut de Veille Sanitaire (InVS). Épidémie de rougeole en France. Actualisation des données de surveillance au 13 mars 2017. [Measles outbreak in France. Updated surveillance data on 13 Mar 2017]. Saint Maurice: InVS. [Accessed 28 May 2017]. French. Available from: http://invs.santepubliquefrance.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Rougeole/Points-d-actualites/Archives/Epidemie-de-rougeole-en-France.-Actualisation-des-donnees-de-surveillance-au-13-mars-2017
  4. Knol M, Urbanus A, Swart E, Mollema L, Ruijs W, van Binnendijk R, et al. Large ongoing measles outbreak in a religious community in the Netherlands since May 2013. Euro Surveill. 2013;18(36):20580.  https://doi.org/10.2807/1560-7917.ES2013.18.36.20580  PMID: 24079377 
  5. Pegorie M, Shankar K, Welfare WS, Wilson RW, Khiroya C, Munslow G, et al. Measles outbreak in Greater Manchester, England, October 2012 to September 2013: epidemiology and control. Euro Surveill. 2014;19(49):20982.  https://doi.org/10.2807/1560-7917.ES2014.19.49.20982  PMID: 25523970 
  6. McCarthy M. Measles outbreak linked to Disney theme parks reaches five states and Mexico. BMJ. 2015;350(jan23 3):h436.  https://doi.org/10.1136/bmj.h436  PMID: 25616478 
  7. Eriksen J, Davidkin I, Kafatos G, Andrews N, Barbara C, Cohen D, et al. Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations? Epidemiol Infect. 2013;141(3):651-66.  https://doi.org/10.1017/S0950268812001136  PMID: 22687578 
  8. Abrams S, Beutels P, Hens N. Assessing mumps outbreak risk in highly vaccinated populations using spatial seroprevalence data. Am J Epidemiol. 2014;179(8):1006-17.  https://doi.org/10.1093/aje/kwu014  PMID: 24573540 
  9. Hens N, Abrams S, Santermans E, Theeten H, Goeyvaerts N, Lernout T, et al. Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013. Euro Surveill. 2015;20(1):20998.  https://doi.org/10.2807/1560-7917.ES2015.20.1.20998  PMID: 25613653 
  10. Abrams S, Kourkouni E, Sabbe M, Beutels P, Hens N. Inferring rubella outbreak risk from seroprevalence data in Belgium. Vaccine. 2016;34(50):6187-92.  https://doi.org/10.1016/j.vaccine.2016.10.072  PMID: 27840011 
  11. Lepoutre A, Antona D, Fonteneau L, Halftermeyer-Zhou F, Baudon C, Dorléans F, et al. Seroprevalence of vaccine-preventable diseases and five other infectious diseases in France. Results of two national surveys 2008-2010. Bull Epidemiol Hebd (Paris). 2013; (41-42):526-34.
  12. Institut de Veille Sanitaire (InVS). Rougeole, rubéole, oreillons / Données / Couverture vaccinale / Maladies à prévention vaccinale / Maladies infectieuses / Dossiers thématiques / Accueil. [Measles, mumps, rubella: Vaccine coverage data]. Saint-Maurice: InVS. [Accessed 6 Jul 2016]. French. Available from: http://invs.santepubliquefrance.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Couverture-vaccinale/Donnees/Rougeole-rubeole-oreillons
  13. Béraud G, Kazmercziak S, Beutels P, Levy-Bruhl D, Lenne X, Mielcarek N, et al. The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases. PLoS One. 2015;10(7):e0133203.  https://doi.org/10.1371/journal.pone.0133203  PMID: 26176549 
  14. Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. Sixth edition. Philadelphia: Elsevier Saunders; 2013.
  15. Waaijenborg S, Hahné SJM, Mollema L, Smits GP, Berbers GAM, van der Klis FRM, et al. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis. 2013;208(1):10-6.  https://doi.org/10.1093/infdis/jit143  PMID: 23661802 
  16. Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ. 2010;340(may18 2):c1626.  https://doi.org/10.1136/bmj.c1626  PMID: 20483946 
  17. Tischer A, Andrews N, Kafatos G, Nardone A, Berbers G, Davidkin I, et al. Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia. Epidemiol Infect. 2007;135(5):787-97.  https://doi.org/10.1017/S0950268807008266  PMID: 17394675 
  18. Anderson RM, May RM. Infectious diseases of humans : dynamics and control. Oxford; New York: Oxford University Press; 1991.
  19. Farrington. Modelling Epidemics. Milton Keynes: Open University Worldwide; 2009.
  20. Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, et al. The basic reproduction number (R0) of measles: a systematic review. Lancet Infect Dis. 2017;17(12):e420-8.  https://doi.org/10.1016/S1473-3099(17)30307-9  PMID: 28757186 
  21. R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2012. Available from: http://www.R-project.org/
  22. Hens N, Ayele GM, Goeyvaerts N, Aerts M, Mossong J, Edmunds JW, et al. Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries. BMC Infect Dis. 2009;9(1):187.  https://doi.org/10.1186/1471-2334-9-187  PMID: 19943919 
  23. Flasche S, Hens N, Boëlle P-Y, Mossong J, van Ballegooijen WM, Nunes B, et al. Different transmission patterns in the early stages of the influenza A(H1N1)v pandemic: a comparative analysis of 12 European countries. Epidemics. 2011;3(2):125-33.  https://doi.org/10.1016/j.epidem.2011.03.005  PMID: 21624784 
  24. Kifle YW, Goeyvaerts N, Van Kerckhove K, Willem L, Kucharski A, Faes C, et al. Animal Ownership and Touching Enrich the Context of Social Contacts Relevant to the Spread of Human Infectious Diseases. PLoS One. 2015;10(7):e0133461.  https://doi.org/10.1371/journal.pone.0133461  PMID: 26193480 
  25. Institut de Veille Sanitaire (InVS). Épidémie de rougeole en France. Actualisation des données de surveillance au 30 mai 2018. [Measles outbreak in France. Updated surveillance data on 30 May 2018]. Saint Maurice: InVS. [Accessed 19 Jun 2018]. French. Available from: http://invs.santepubliquefrance.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Rougeole/Points-d-actualites/Bulletin-epidemiologique-rougeole.-Donnees-de-surveillance-au-30-mai-2018
  26. Cliff A, Haggett P. Time, travel and infection. Br Med Bull. 2004;69(1):87-99.  https://doi.org/10.1093/bmb/ldh011  PMID: 15226199 
  27. Mina MJ, Metcalf CJE, de Swart RL, Osterhaus ADME, Grenfell BT. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science. 2015;348(6235):694-9.  https://doi.org/10.1126/science.aaa3662  PMID: 25954009 
  28. Spencer HC, Kaseje DC, Mosley WH, Sempebwa EK, Huong AY, Roberts JM. Impact on mortality and fertility of a community-based malaria control programme in Saradidi, Kenya. Ann Trop Med Parasitol. 1987;81(sup1) Suppl 1;36-45.  https://doi.org/10.1080/00034983.1987.11812187  PMID: 3689036 
  29. Te Beest DE, Birrell PJ, Wallinga J, De Angelis D, van Boven M. Joint modelling of serological and hospitalization data reveals that high levels of pre-existing immunity and school holidays shaped the influenza A pandemic of 2009 in the Netherlands. J R Soc Interface. 2015;12(103):20141244.  https://doi.org/10.1098/rsif.2014.1244  PMID: 25540241 
  30. Ali ST, Kadi AS, Ferguson NM. Transmission dynamics of the 2009 influenza A (H1N1) pandemic in India: the impact of holiday-related school closure. Epidemics. 2013;5(4):157-63.  https://doi.org/10.1016/j.epidem.2013.08.001  PMID: 24267871 
  31. Davis BM, Markel H, Navarro A, Wells E, Monto AS, Aiello AE. The effect of reactive school closure on community influenza-like illness counts in the state of Michigan during the 2009 H1N1 pandemic. Clin Infect Dis. 2015;60(12):e90-7.  https://doi.org/10.1093/cid/civ182  PMID: 25896795 
  32. Keogh-Brown MR, Smith RD, Edmunds JW, Beutels P. The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands. Eur J Health Econ. 2010;11(6):543-54.  https://doi.org/10.1007/s10198-009-0210-1  PMID: 19997956 
  33. Institut National de Veille Sanitaire (InVS). Couverture vaccinale des enfants et des adolescents en France : résultats des enquêtes menées en milieu scolaire 2001-2004. [Vaccination coverage of children and adolescents in France: results of school-based surveys, 2001-2004]. Saint-Maurice: InVS; 2007.French. [Accessed 19 Jun 2018]. Available from: http://opac.invs.sante.fr/doc_num.php?explnum_id=3535
  34. Pebody RG, Edmunds WJ, Conyn-van Spaendonck M, Olin P, Berbers G, Rebiere I, et al. The seroepidemiology of rubella in western Europe. Epidemiol Infect. 2000;125(2):347-57.  https://doi.org/10.1017/S0950268899004574  PMID: 11117958 
  35. Cortese MM, Barskey AE, Tegtmeier GE, Zhang C, Ngo L, Kyaw MH, et al. Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. J Infect Dis. 2011;204(9):1413-22.  https://doi.org/10.1093/infdis/jir526  PMID: 21933874 
  36. Rota JS, Hickman CJ, Sowers SB, Rota PA, Mercader S, Bellini WJ. Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission. J Infect Dis. 2011;204(Suppl 1):S559-63.  https://doi.org/10.1093/infdis/jir098  PMID: 21666213 
  37. Hahné SJM, Nic Lochlainn LM, van Burgel ND, Kerkhof J, Sane J, Yap KB, et al. Measles Outbreak Among Previously Immunized Healthcare Workers, the Netherlands, 2014. J Infect Dis. 2016;214(12):1980-6.  https://doi.org/10.1093/infdis/jiw480  PMID: 27923955 
  38. Bollaerts K, Aerts M, Shkedy Z, Faes C, Van der Stede Y, Beutels P, et al. Estimating the population prevalence and force of infection directly from antibody titres. Stat Model. 2012;12(5):441-62.  https://doi.org/10.1177/1471082X12457495 
  39. Umlauf BJ, Haralambieva IH, Ovsyannikova IG, Kennedy RB, Pankratz VS, Jacobson RM, et al. Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination. Viral Immunol. 2012;25(1):29-36. PMID: 22239234 
  40. Sniadack DH, Mendoza-Aldana J, Huyen DTT, Van TTT, Cuong NV, Olive JM, et al. Epidemiology of a measles epidemic in Vietnam 2008-2010. J Infect Dis. 2011;204(Suppl 1):S476-82.  https://doi.org/10.1093/infdis/jir092  PMID: 21666203 
  41. Aaby P. Influence of cross-sex transmission on measles mortality in rural Senegal. Lancet. 1992;340(8816):388-91.  https://doi.org/10.1016/0140-6736(92)91470-S  PMID: 1353555 
Resurgence risk for measles, mumps and rubella in France in 2018 and 2020
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Guillaume+B%C3%A9raud&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Béraud Guillaume</a>, <a href="/search?value1=Steven+Abrams&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Abrams Steven</a>, <a href="/search?value1=Philippe+Beutels&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Beutels Philippe</a>, <a href="/search?value1=Benoit+Dervaux&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Dervaux Benoit</a>, <a href="/search?value1=Niel+Hens&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hens Niel</a></span>. Resurgence risk for measles, mumps and rubella in France in 2018 and 2020. <a href="/content/ecdc">Euro Surveill.</a> 2018;23(25):pii=1700796. <a href="https://doi.org/10.2807/1560-7917.ES.2018.23.25.1700796" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2018.23.25.1700796</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 28 Nov 2017;&nbsp;&nbsp; <span class="generated">Accepted</span>: 20 Apr 2018 </span> </p>
/content/10.2807/1560-7917.ES.2018.23.25.1700796
/content/10.2807/1560-7917.ES.2018.23.25.1700796
Loading

Data & Media loading...

Supplementary data

  • Download

    • Supplementary material for Beraud et al

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error